Flavins as Covalent Catalysts: New Mechanisms Emerge

Trends in Biochemical Sciences

Volumn 42, Issue 6, 2017, Pages 457-469

  Piano, Valentina ^a   Palfey, Bruce A ^b   Mattevi, Andrea ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ENTEROCIN; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FLAVOPROTEIN; HISTONE DEMETHYLASE; MUTASE; NATURAL PRODUCT; OXIDOREDUCTASE; PARGYLINE; RASAGILINE; RIBOFLAVIN; THYMIDYLATE SYNTHASE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOPYRANOSE MUTASE; RIBOFLAVIN DERIVATIVE;

ANTIBIOTIC BIOSYNTHESIS; BIOTRANSFORMATION; CATALYSIS; COVALENT BOND; CYCLOADDITION; DECARBOXYLATION; DEPRESSION; DRUG TARGETING; ELECTRON TRANSPORT; ENZYME ACTIVE SITE; ENZYME SUBSTRATE COMPLEX; HUMAN; ISOMERIZATION; MICHAEL ADDITION; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; BIOCATALYSIS; CHEMISTRY; METABOLISM;

BIOCATALYSIS; FLAVINS; OXIDATION-REDUCTION; OXIDOREDUCTASES;

EID: 85014390371     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2017.02.005     Document Type: Review

References (81)

1. Moonen, C.T., et al. Reinvestigation of the structure of oxidized and reduced flavin: carbon-13 and nitrogen-15 nuclear magnetic resonance study. Biochemistry 23 (1984), 4859–4867.
2. Gadda, G., Flavins. Roberts, G.C.K., (eds.) Encyclopedia of Biophysics, 2013, Springer, 771–775.
3. Walsh, C.T., Wencewicz, T.A., Flavoenzymes: versatile catalysts in biosynthetic pathways. Nat. Prod. Rep. 30 (2013), 175–200.
4. Haas, E., Isolierung eines neuen gelben Ferments. Biochem. Z. 298 (1938), 378–390.
5. Nakamura, T., et al. Action mechanism of the old yellow enzyme. J. Biochem. 57 (1965), 554–564.
6. Walsh, C., Chemical approaches to the study of enzymes catalyzing redox transformations. Annu. Rev. Biochem. 47 (1978), 881–931.
7. Bornemann, S., Flavoenzymes that catalyse reactions with no net redox change. Nat. Prod. Rep. 19 (2002), 761–772.
8. Williams, R.E., Bruce, N.C., ‘New uses for an old enzyme’ – the old yellow enzyme family of flavoenzymes. Microbiology 148 (2002), 1607–1614.
9. Minshull, J., et al. Predicting enzyme function from protein sequence. Curr. Opin. Chem. Biol. 9 (2005), 202–209.
10. Macheroux, P., et al. Flavogenomics–a genomic and structural view of flavin-dependent proteins. FEBS J. 278 (2011), 2625–2634.
11. Fagan, R.L., Palfey, B.A., Flavin-dependent enzymes. Compr. Nat. Prod. 2 (2010), 37–113.
12. Jortzik, E., et al. Flavins and flavoproteins: applications in medicine. Methods Mol. Biol. 1146 (2014), 113–157.
13. Massey, V., Introduction: flavoprotein structure and mechanism. FASEB J. 9 (1995), 473–475.
14. Stuehr, D.J., et al. Structural and mechanistic aspects of flavoproteins: electron transfer through the nitric oxide synthase flavoprotein domain. FEBS J. 276 (2009), 3959–3974.
15. Peters, J.W., et al. Electron bifurcation. Curr. Opin. Chem. Biol. 31 (2016), 146–152.
16. Fraaije, M., Mattevi, A., Flavoenzymes: diverse catalysts with recurrent features. Trends Biochem. Sci. 25 (2000), 126–132.
17. De Colibus, L., Mattevi, A., New frontiers in structural flavoenzymology. Curr. Opin. Struc. Biol. 16 (2006), 722–728.
18. Schulz, G.E., et al. The structure of the flavoenzyme glutathione reductase. Nature 273 (1978), 120–124.
19. Wierenga, R.K., et al. Prediction of the occurrence of the ADP-binding βαβ-fold in proteins, using an amino acid sequence fingerprint. J. Mol. Biol. 187 (1986), 101–107.
20. van Beek, H.L., et al. Blending Baeyer-Villiger monooxygenases: using a robust BVMO as a scaffold for creating chimeric enzymes with novel catalytic properties. Chem. Commun. 48 (2012), 3288–3290.
21. Sobrado, P., Noncanonical reactions of flavoenzymes. Int. J. Mol. Sci. 13 (2012), 16751–16768.
22. Teufel, R., et al. Unusual flavoenzyme catalysis in marine bacteria. Curr. Opin. Chem. Biol. 31 (2016), 31–39.
23. Walker, W.H., et al. Reduktive photoalkylierung des flavinkerns und flavinkatalysierte photodecarboxylierung von phenylacetat studien in der flavinreihe. Helv. Chim. Acta 50 (1967), 2269–2279.
24. Porter, D.J.T., et al. Direct evidence for carbanions and covalent n5-flavin-carbanion adducts as catalytic intermediates in the oxidation of nitroethane by D-amino acid oxidase. J. Biol. Chem. 248 (1973), 4400–4416.
25. Hevesi, L., Bruice, T.C., Reaction of sulfite with isoalloxazines. Biochemistry 12 (1973), 290–297.
26. Massey, V., et al. Studies on milk xanthine oxidase: some spectral and kinetic properties. J. Biol. Chem. 244 (1969), 1682–1691.
27. Macheroux, P., UV-visible spectroscopy as a tool to study flavoproteins. Methods Mol. Biol. 131 (1999), 1–7.
28. Kopriva, S., et al. Plant adenosine 5′-phosphosulfate reductase is a novel iron-sulfur protein. J. Biol. Chem. 276 (2001), 42881–42886.
29. Schiffer, A., et al. Reaction mechanism of the iron-sulfur flavoenzyme adenosine-5′-phosphosulfate reductase based on the structural characterization of different enzymatic states. Biochemistry 45 (2006), 2960–2967.
30. Vervoort, J., et al. Identifications of the true carbon-13 nuclear magnetic resonance spectrum of the stable intermediate II in bacterial luciferase. Biochemistry 25 (1986), 8062–8067.
31. Mattevi, A., To be or not to be an oxidase: challenging the oxygen reactivity of flavoenzymes. Trends Biochem. Sci. 31 (2006), 276–283.
32. Chaiyen, P., et al. The enigmatic reaction of flavins with oxygen. Trends Biochem. Sci. 37 (2012), 373–380.
33. Hille, R., et al. Handbook of Flavoproteins. 2012, De Gruyter.
34. Soltero-Higgin, M., Identification of inhibitors for UDP-galactopyranose mutase. J. Am. Chem. Soc. 34 (2004), 10532–11263.
35. Kincaid, V.A., et al. Virtual screening for UDP-galactopyranose mutase ligands identifies a new class of antimycobacterial agents. ACS Chem. Biol. 10 (2015), 2209–2218.
36. Partha, S.K., et al. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. J. Mol. Biol. 394 (2009), 864–877.
37. Ansiaux, C., et al. Reversible and efficient inhibition of UDP-galactopyranose mutase by electrophilic, constrained and unsaturated UDP-galactitol analogues. Chem. Eur. J. 18 (2012), 14860–14866.
38. Tanner, J.J., et al. Structure, mechanism, and dynamics of UDP-galactopyranose mutase. Arch. Biochem. Biophys. 544 (2014), 128–141.
39. Zhang, Q., Liu, H.-W., Mechanistic investigation of UDP-galactopyranose mutase from Escherichia coli using 2- and 3-fluorinated UDP-galactofuranose as probes. J. Am. Chem. Soc. 123 (2001), 6756–6766.
40. Oppenheimer, M., et al. Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas’ disease. PLoS One, 7, 2012, e32918.
41. Mehra-Chaudhary, R., In crystallo capture of a covalent intermediate in the UDP-galactopyranose mutase reaction. Biochemistry 55 (2016), 833–836.
42. Benjamin, D.I., et al. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 14912–14917.
43. Piano, V., et al. Discovery of inhibitors for the ether lipid-generating enzyme AGPS as Anti-cancer agents. ACS Chem. Biol. 10 (2015), 2589–2597.
44. Razeto, A., et al. The crucial step in ether phospholipid biosynthesis: structural basis of a noncanonical reaction associated with a peroxisomal disorder. Structure 15 (2007), 683–692.
45. Nenci, S., et al. Precursor of ether phospholipids is synthesized by a flavoenzyme through covalent catalysis. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 18791–18796.
46. Leferink, N.G., et al. The growing VAO flavoprotein family. Arch. Biochem. Biophys. 474 (2008), 292–301.
47. Urbonavicius, J., et al. Identification of a novel gene encoding a flavin-dependent tRNA:m5U methyltransferase in bacteria–evolutionary implications. Nucleic Acids Res. 33 (2005), 3955–3964.
48. Myllykallio, H., et al. An alternative flavin-dependent mechanism for thymidylate synthesis. Science 297 (2002), 105–107.
49. Munch-Petersen, A., Metabolism of Nucleotides, Nucleosides and Nucleobases in Microorganisms. 1983, Academic Press.
50. Nishimasu, H., et al. Atomic structure of a folate/FAD-dependent tRNA T54 methyltransferase. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 8180–8185.
51. Koehn, E.M., et al. Folate binding site of flavin-dependent thymidylate synthase. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 15722–15727.
52. Hamdane, D., et al. Insights into folate/FAD-dependent tRNA methyltransferase mechanism: role of two highly conserved cysteines in catalysis. J. Biol. Chem. 286 (2011), 36268–36280.
53. Hamdane, D., et al. FAD/Folate-dependent tRNA methyltransferase: flavin as a new methyl-transfer agent. J. Am. Chem. Soc. 134 (2012), 19739–19745.
54. Hamdane, D., et al. Activation of a unique flavin-dependent tRNA-methylating agent. Biochemistry 52 (2013), 8949–8956.
55. Stull, F.W., et al. Deprotonations in the reaction of flavin-dependent thymidylate synthase. Biochemistry 55 (2016), 3261–3269.
56. Conrad, J.A., et al. Detection of intermediates in the oxidative half-reaction of the FAD-dependent thymidylate synthase from Thermotoga maritima: carbon transfer without covalent pyrimidine activation. Biochemistry 53 (2014), 5199–5207.
57. Mishanina, T.V., et al. An unprecedented mechanism of nucleotide methylation in organisms containing thyX. Science 351 (2016), 507–510.
58. Kawamukai, M., Biosynthesis of coenzyme Q in eukaryotes. Biosci. Biotechnol. Biochem. 80 (2015), 23–33.
59. Payne, K.A., et al. New cofactor supports α,β-unsaturated acid decarboxylation via 1,3-dipolar cycloaddition. Nature 522 (2015), 497–501.
60. Marshall, S.A. et al. (2017) Oxidative maturation and structural characterization of prenylated-FMN binding by UbiD, a decarboxylase involved in bacterial ubiquinone biosynthesis. J. Biol. Chem. Published online January 5, 2017. http://dx.doi.org/jbc.M116.762732.
61. White, M.D., et al. UbiX is a flavin prenyltransferase required for bacterial ubiquinone biosynthesis. Nature 522 (2015), 502–506.
62. Baunach, M., Hertweck, C., Natural 1,3-dipolar cycloadditions. Angew. Chem. Int. Ed. Engl. 54 (2015), 12550–12552.
63. Leys, D., Scrutton, N.S., Sweating the assets of flavin cofactors: new insight of chemical versatility from knowledge of structure and mechanism. Curr. Opin. Struc. Biol. 41 (2016), 19–26.
64. Huijbers, M.M., et al. Flavin dependent monooxygenases. Arch. Biochem. Biophys. 544 (2014), 2–17.
65. Xiang, L.K., et al. Mutational analysis of the enterocin Favorskii biosynthetic rearrangement. Org. Lett. 4 (2002), 957–960.
66. Xiang, L., et al. EncM, a versatile enterocin biosynthetic enzyme involved in Favorskii oxidative rearrangement, aldol condensation, and heterocycle-forming reactions. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15609–15614.
67. Teufel, R., et al. Flavin-mediated dual oxidation controls an enzymatic Favorskii-type rearrangement. Nature 503 (2013), 552–556.
68. Teufel, R., et al. Biochemical establishment and characterization of EncM's flavin-N5-oxide cofactor. J. Am. Chem. Soc. 137 (2015), 8078–8085.
69. Adak, S., Begley, T.P., Dibenzothiophene catabolism proceeds via a flavin-N5-oxide intermediate. J. Am. Chem. Soc. 138 (2016), 6424–6426.
70. Huijbers, M.M., et al. Flavin dependent monooxygenases. Arch. Biochem. Biophys. 544 (2014), 2–17.
71. Edmondson, D.E., et al. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry 48 (2009), 4220–4230.
72. Zeller, E.A., A new approach to the analysis of the interaction between monoamineoxidase and its substrates and inhibitors. Annu. N. Y. Acad. Sci. 107 (1963), 811–821.
73. Gärtner, B., et al. Structure of flavin adducts with acetylenic substrates: chemistry of monoamine oxidase and lactate oxidase inhibition. Eur. J. Biochem. 63 (1976), 211–221.
74. Binda, C., et al. Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class. J. Med. Chem. 47 (2004), 1767–1774.
75. Hubálek, F., et al. Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. J. Med. Chem. 47 (2004), 1760–1766.
76. Stazi, G., et al. LSD1 inhibitors: a patent review (2010–2015). Expert. Opin. Ther. Pat. 26 (2016), 565–580.
77. Zheng, Y.C., et al. Irreversible LSD1 inhibitors: application of tranylcypromine and its derivatives in cancer treatment. Curr. Top. Med. Chem. 16 (2016), 2179–2188.
78. Binda, C., et al. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. J. Am. Chem. Soc. 132 (2010), 6827–6833.
79. Mathews, I.I., Flavin-dependent thymidylate synthase as a drug target for deadly microbes: mutational study and a strategy for inhibitor design. J. Bioterror. Biodef., 12, 2013, 004.
80. Speers, A.E., Cravatt, B.F., Profiling enzyme activities in vivo using click chemistry methods. Chem. Biol. 11 (2004), 535–546.
81. Krysiak, J.M., et al. Activity-based probes for studying the activity of flavin-dependent oxidases and for the protein target profiling of monoamine oxidase inhibitors. Angew. Chem. Int. Ed. 51 (2012), 7035–7040.